Kolkata: Bengal Chemicals and Pharmaceutical Company has received the license to produce Hydroxychloroquine, an anti-malarial drug that is being touted as “game changer” in the fight against COVID-19 pandemic, a top company official said.
The Drug Controller General of India has allowed Bengal Chemicals to produce 200 mg and 400 mg Hydroxychloroquine tablets, company Managing Director PM Chandraiah said on Friday.
“We are ready to do the formulation without any profit as a gesture to fight COVID-19,” news agency PTI quoted Chandraiah as saying.
The company can produce 10 lakh tablets a day and can ramp it up to 15 lakhs, he said.
“But, the question is raw material. The government has to arrange raw materials or active pharmaceutical ingredients (API). We have failed to arrange it from our end,” he added.
